Senate FDA bill clears committee, would modify regulatory framework for lab developed tests 聽
The Senate Health, Education, Labor & Pensions Committee last night voted 13-9 that would reauthorize Food and Drug Administration user fee programs and modify the regulatory framework for laboratory developed tests. AHA last week urged lawmakers to consider certain changes to the LDT provisions to ensure continued access to these critical tests.
The House last week passed its own bill (H.R. 7667) to reauthorize FDA user fee programs, which does not include the LDT provisions. Among other provisions, the House bill would include drugs on the FDA鈥檚 shortages list in a pilot program to designate advanced manufacturing technologies.
Related News Articles
Headline
The House committees with jurisdiction over Medicaid and other health care programs have announced they will begin marking up their portions of the budget鈥
Headline
The AHA May 8 voiced support for the Save Healthcare Workers Act to House and Senate sponsors of the legislation. The bipartisan bill would make it a federal鈥
Headline
President Trump today released his discretionary spending budget blueprint for fiscal year 2026. The 鈥渟kinny budget鈥 request, which includes top line鈥
Headline
The House Energy and Commerce Committee held a markup April 29 where it advanced the AHA-supported SUPPORT Act (H.R. 2483). The legislation would reauthorize鈥
Perspective
Congressional lawmakers are heading home for a two-week district work period after both the Senate and House passed a revised budget resolution for fiscal year鈥
Headline
Story Updated April 5 at 8:30 a.m. ETThe Senate by a vote of 51 to 48 passed its revised budget resolution for fiscal year 2025 with Sens. Rand鈥